Check out the companies making headlines before the bell: Celgene agreed to sell the rights to its Otezla psoriasis drug to Amgen for $13.4 billion in cash. Bristol-Myers Squibb had previously agreed to the Otezla divestiture to win approval for its pending …
See Original Article
Amid the Chicken Sandwich Wars of 2019, the granddaddy of fried chicken is looking beyond. KFC announced Monday it becomes the first national fast-food chain to introduce a plant-based chicken in partnership with El Segundo, California-based Beyond …
See Original Article
STORE Capital Corporation (NYSE:STOR) closed yesterday at $36.67, which left some investors asking whether the high earnings potential can still
See Original Article
âDon Spring has been a key member of our finance department for a decade and has done an outstanding job of managing our accounting functions
See Original Article
European equities and US futures slid on Tuesday after Germany confirmed its economy shrank 0.1% last quarter. German business confidence has slumped to its lowest level in more than six years, a recent survey found. Recent escalation in the US-China …
See Original Article
Leave a Reply